Literature DB >> 22075267

Replication and meta-analysis of the gene-environment interaction between body mass index and the interleukin-6 promoter polymorphism with higher insulin resistance.

Patricia C Underwood1, Bindu Chamarthi, Jonathan S Williams, Bei Sun, Anand Vaidya, Benjamin A Raby, Jessica Lasky-Su, Paul N Hopkins, Gail K Adler, Gordon H Williams.   

Abstract

Insulin resistance (IR) is a complex disorder caused by an interplay of both genetic and environmental factors. Recent studies identified a significant interaction between body mass index (BMI) and the rs1800795 polymorphism of the interleukin-6 gene that influences both IR and onset of type 2 diabetes mellitus, with obese individuals homozygous for the C allele demonstrating the highest level of IR and greatest risk for type 2 diabetes mellitus. Replication of a gene-environment interaction is important to confirm the validity of the initial finding and extend the generalizability of the results to other populations. Thus, the objective of this study was to replicate this gene-environment interaction on IR in a hypertensive population and perform a meta-analysis with prior published results. The replication analysis was performed using white individuals with hypertension from the Hypertensive Pathotype cohort (N = 311), genotyped for rs1800795. Phenotype studies were conducted after participants consumed 2 diets--high sodium (200 mmol/d) and low sodium (10 mmol/d)--for 7 days each. Measurements for plasma glucose, insulin, and interleukin-6 were obtained after 8 hours of fasting. Insulin resistance was characterized by the homeostatic model assessment (HOMA-IR). In Hypertensive Pathotype, BMI was a significant effect modifier of the relationship between rs1800795 and HOMA-IR; higher BMI was associated with higher HOMA-IR among homozygote CC individuals when compared with major allele G carriers (P = .003). Furthermore, the meta-analysis in 1028 individuals confirmed the result, demonstrating the same significant interaction between rs1800795 and BMI on HOMA-IR (P = 1.05 × 10(-6)). This rare replication of a gene-environment interaction extends the generalizability of the results to hypertension while highlighting this polymorphism as a marker of IR in obese individuals.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22075267      PMCID: PMC3461261          DOI: 10.1016/j.metabol.2011.09.018

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  25 in total

1.  IL-6 promoter polymorphisms and quantitative traits related to the metabolic syndrome in KORA S4.

Authors:  Harald Grallert; Cornelia Huth; Melanie Kolz; Christa Meisinger; Christian Herder; Klaus Strassburger; Guido Giani; H-Erich Wichmann; Jerzy Adamski; Thomas Illig; Wolfgang Rathmann
Journal:  Exp Gerontol       Date:  2006-06-23       Impact factor: 4.032

Review 2.  IL-6 signal transduction and its physiological roles: the signal orchestration model.

Authors:  D Kamimura; K Ishihara; T Hirano
Journal:  Rev Physiol Biochem Pharmacol       Date:  2003-04-05       Impact factor: 5.545

3.  Pattern of expression of inflammatory markers in adipose tissue of untreated hypertensive patients.

Authors:  Stephanie Madec; Massimo Chiarugi; Eleonora Santini; Chiara Rossi; Paolo Miccoli; Ele Ferrannini; Anna Solini
Journal:  J Hypertens       Date:  2010-07       Impact factor: 4.844

4.  Interleukin-6 gene polymorphism and insulin sensitivity.

Authors:  J M Fernández-Real; M Broch; J Vendrell; C Gutiérrez; R Casamitjana; M Pugeat; C Richart; W Ricart
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

5.  Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes.

Authors:  Y H Hamid; C S Rose; S A Urhammer; C Glümer; R Nolsøe; O P Kristiansen; T Mandrup-Poulsen; K Borch-Johnsen; T Jorgensen; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  2005-01-11       Impact factor: 10.122

6.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

7.  Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes.

Authors:  Matthias Möhlig; Heiner Boeing; Joachim Spranger; Martin Osterhoff; Anja Kroke; Eva Fisher; Manuela M Bergmann; Michael Ristow; Kurt Hoffmann; Andreas F H Pfeiffer
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

8.  Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes.

Authors:  T Illig; F Bongardt; A Schöpfer; S Müller-Scholze; W Rathmann; W Koenig; B Thorand; C Vollmert; R Holle; H Kolb; C Herder
Journal:  J Clin Endocrinol Metab       Date:  2004-10       Impact factor: 5.958

9.  The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity.

Authors:  Agata Kubaszek; Jussi Pihlajamäki; Kari Punnonen; Pauli Karhapää; Ilkka Vauhkonen; Markku Laakso
Journal:  Diabetes       Date:  2003-02       Impact factor: 9.461

10.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

View more
  6 in total

Review 1.  Genetic polymorphisms of cytokine genes in type 2 diabetes mellitus.

Authors:  Monisha Banerjee; Madhukar Saxena
Journal:  World J Diabetes       Date:  2014-08-15

2.  The influence of sodium- and calcium-regulatory hormone interventions on adipocytokines in obesity and diabetes.

Authors:  Anand Vaidya; Patricia C Underwood; Justin P Annes; Bei Sun; Gordon H Williams; John P Forman; Jonathan S Williams
Journal:  Metabolism       Date:  2012-11-09       Impact factor: 8.694

Review 3.  The importance of gene-environment interactions in human obesity.

Authors:  Hudson Reddon; Jean-Louis Guéant; David Meyre
Journal:  Clin Sci (Lond)       Date:  2016-09-01       Impact factor: 6.124

4.  Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter.

Authors:  Robert M Carey; Cynthia D Schoeffel; John J Gildea; John E Jones; Helen E McGrath; Lindsay N Gordon; Min Jeong Park; Rafal S Sobota; Patricia C Underwood; Jonathan Williams; Bei Sun; Benjamin Raby; Jessica Lasky-Su; Paul N Hopkins; Gail K Adler; Scott M Williams; Pedro A Jose; Robin A Felder
Journal:  Hypertension       Date:  2012-09-17       Impact factor: 10.190

Review 5.  Association between -174G>C polymorphism in the IL-6 promoter region and the risk of obesity: A meta-analysis.

Authors:  Man Hu; Zhaomin Yu; Dan Luo; Haiming Zhang; Jinxiao Li; Fengxia Liang; Rui Chen
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

6.  Interleukin-6 (IL-6)-597 A/G (rs1800797) & -174 G/C (rs1800795) gene polymorphisms in type 2 diabetes.

Authors:  Madhukar Saxena; C G Agrawal; Neena Srivastava; Monisha Banerjee
Journal:  Indian J Med Res       Date:  2014-07       Impact factor: 2.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.